跳至主要内容
临床试验/ITMCTR2000003817
ITMCTR2000003817尚未招募1 期

A study of the efficacy of musk in the treatment of microcirculation disturbance after PPCI in acute ST-segment elevation myocardial infarction

onghua Hospital affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
30 至 80(—)
性别
All

入选标准

  • (1) AMI met WHO diagnostic criteria: persistent chest pain >30 minutes; Myocardial enzymes increased twice the normal value; St-segment elevation of two adjacent leads on the electrocardiogram >0.1mv;
  • (2) Patients with first myocardial infarction;
  • (3) Coronary angiography was performed to confirm complete occlusion of the criminal's blood vessels and direct PCI was performed;
  • (4) All patients took aspirin, Bolivar, statins, lipid-lowering drugs and other drugs to inhibit in-stent restenosis as prescribed by the doctor after surgery;
  • (5) No angina attack.

排除标准

  • 1. Patients with coagulation dysfunction and severe liver and kidney dysfunction;
  • 2. Patients with heart disease, severe pulmonary hypertension, uncontrolled hypertension, and adults with right-to-left shunt
  • 3. Patients with suction distress syndrome;
  • 4. With other heart diseases, such as rheumatic heart disease, congenital heart disease, etc.;
  • 5. Severe arrhythmia, including frequent pre-ventricular contraction, paroxysmal ventricular tachycardia, atrial fibrillation;
  • 6. A history of drug allergy.

研究者

发起方
onghua Hospital affiliated to Shanghai University of Traditional Chinese Medicine

相似试验